TYRP1 transcript levels, which were almost the same in drug-naïve, vemurafenib-resistant and on-drug-holiday BRAFV600E melanoma cells, were not markedly altered also in cells only shortly exposed to vemurafenib (Fig. 2c). Here, TYRP1 is linked to melanoma.